No, the one percentage point FMAP increase does not pertain to prescribed drugs (including over-the-counter drugs prescribed by a healthcare professional) that are claimed on the "Prescribed Drugs" line of the CMS-64 form. However, the one percentage point FMAP increase applies to injectable drugs that receive a United States Preventive Services Task Force (USPSTF) grade A or B recommendation and are provided in a clinical setting for the primary purpose of prevention. Cost-sharing should be waived for such services.
Supplemental Links:
- This FAQ was released as part of a larger set. View the full set. (PDF, 159.52 KB)